会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
    • 3(2H)哒嗪酮,它们的制备方法和含有抗过敏剂。
    • EP0201765A2
    • 1986-11-20
    • EP86105537.4
    • 1986-04-22
    • NISSAN CHEMICAL INDUSTRIES LTD.
    • Mutsukado, MotooTanikawa, KeizoShikada, Ken-ichiSakoda, Ryozo
    • A61K31/50C07D237/22
    • A61K31/50C07D237/22
    • A 3(2H)pyridazinone of the formula:
      wherein R 1 is hydrogen, methyl, C 3 -C 6 alkenyl, C 5 or C 6 cycloalkyl, benzyl, phenyl, -(CH 2 ) m CO 2 R 3 (wherein R 3 is hydrogen or C 1 -C 5 alkyl, and m is an integer of from 1 to 4), -(CH 2 ) n A (wherein A is -OH or-N(R 4 ) 2 wherein R 4 is C 1 -C 3 alkyl, and n is an integer of from 2 to 6) or -CH 2 CF 3 ; R 2 is chlorine or bromine; each of Y 1 and Y 2 which may be the same or different, is hydrogen, C 1 -C 5 alkyl, C 2 -C 8 alkenyl, halogen, -OR 5 (wherein R 5 is hydrogen, C 1 -C 8 alkyl or
      wherein q is an integer of from 1 to 4),-CO 2 R 6 (wherein R 6 is hydrogen or C 1 -C 5 alkyl),-N(R 7 ) 2 (wherein R 7 is C 1 -C 4 alkyl) or-SR 8 (wherein R 8 is C 1 -C 4 alkyl); and Y 3 is C 1 -C 5 alkyl, C 2 -C 8 alkenyl, halogen, -OR 5 (wherein R 5 is as defined above), -CO 2 R 6 (wherein R 6 is as defined above), -N(R 7 ) 2 (wherein R 7 is as defined above) or-SR 8 (wherein R 8 is as defined above), or a pharmaceutically acceptable salt thereof.
    • 式A 3(2H)哒嗪酮: worin R1是氢,甲基,C3-C6链烯基,C5或C6环烷基,苄基,苯基, - (CH2)mCO2R3(worin R3是氢或C1-C5烷基, 且m是从1到4的整数), - (CH 2)NA(worin A是-OH或-N(R 4)2 worin R4是C1-C3烷基,且n为2至6)或的整数 - CF 3; R 2是氯或溴; 氢中,Y1和Y2的其中可以是相同或不同的,是氢,C,C5烷基,C2-C8链烯基,卤素,-OR 5(R 5是worin,C1-C8烷基或 worin q是整数 (从1到4的),-CO2R6 worin R6是氢或C1-C5烷基), - N(R 7)2(worin R7是C1-C4烷基)或-SR 8(worin R8是C1-C4烷基); 和Y 3是C1-C5烷基,C2-C8链烯基,卤素,-OR 5(worin R5是如上定义的),是-CO2R6如上所定义), - N(R 7)2(R 7 worin如上所定义)或 - SR8(worin R8是如上定义的),或其药学上可接受的盐。
    • 2. 发明公开
    • 3(2H)pyridazinone, process for its preparation and anti-allergic agent containing it
    • 3(2H)哒嗪酮,其制备方法和含有该抗过敏剂的过程。
    • EP0186817A1
    • 1986-07-09
    • EP85115655.4
    • 1985-12-09
    • NISSAN CHEMICAL INDUSTRIES LTD.
    • Mutsukado, MotooTanikawa, KeizoShikada, Ken-ichiSakoda, Ryozo
    • C07D237/22A61K31/50
    • C07D405/12C07D237/22Y10S514/826
    • A 3(2H)pyridazinone of the formula:
      wherein R, is C 2 -C 5 alkyl; R 2 is hydrogen, C 1 -C 3 alkyl, chlorine or bromine; R 3 is hydrogen or C 1 -C 4 alkyl; and each of Y 1 , Y 2 and Y 3 which may be the same or different, is hydrogen, C 1 -C 8 alkyl. C 2 -C 8 alkenyl, halogen, -(CH 2 ),A [wherein A is substituted amino of the formula -N(R 4 )(R 5 ) (wherein each of R 4 and R 5 which may be the same or different, is C 1 -C 4 alkyl, or R 4 and R 5 together form C 4- C 5 alkylene), morpholino, 4-R 6 -piperazin-1-yl (wherein R 6 is C 1 -C 3 alkyl) or-OR 7 (wherein R 7 is hydrogen or C,-C 3 alkyl), and I is an integer of 0 to 3], -OR 8 [wherein R 8 is hydrogen, C 1 -C 8 alkyl, C 3 -C 5 alkenyl, benzyl or -(CH 2 ) q R 9 [wherein R 9 is CO 2 R 3 (wherein R 3 is as defined above), -CONHR 3 (wherein R 3 is as defined above) or -CH 2 OR 7 (wherein R 7 is as defined above), and q is an integer of 1 to 5]], -CO 2 R 3 (wherein R 3 is as defined above), -CON(R 10 )(R 11 ) [wherein each of R, o and R,, which may be the same or different, is hydrogen, C 1 -C 4 alkyl or C 3 -C 5 alkenyl, or R 10 and R 11 together form C 1 -C 6 alkylene, -(CH 2 ) 2 O(CH 2 ) 2 or -(CH 2 ) 2 N(R 6 )(CH 2 ) 2 - (wherein R 6 is as defined above)], -CONH(CH 2 ) m A (wherein A is as defined above, and m is an integer of 2 to 4), -CH = CHCOR, 2 (wherein R 12 is hydroxy, C 1 -C 4 alkoxy or -N(R 13 )(CH 2 ) n CO 2 R 3 (wherein R 13 is hy- d rogen, C 1 -C 6 alkyl or cycloalkyl, R 3 is as defined above, and n is an integer of 1 to 4)), -SR 14 (wherein R 14 is C 1 -C 4 alkyl),
      (wherein R 3 is as defined above), or two of Y 1 Y 2 and Y 3 together form
      (wherein p is an integer of 1 or 2), and a pharmaceutically acceptable salt thereof.
    • 8. 发明公开
    • 3(2H)pyridazinone, process for its preparation and antagonistic agent against SRS-A containing it
    • 3(2H)哒嗪酮,其制备方法和含有针对SRS-A这个代理进程。
    • EP0275997A1
    • 1988-07-27
    • EP88100798.3
    • 1988-01-20
    • NISSAN CHEMICAL INDUSTRIES LTD.
    • Tanikawa, KeizoSakoda, RyozoShikada, Ken-ichi Nissan Chemical Ind. Ltd.,Sakuya, Tanaka Nissan Chemical Ind. Ltd.,
    • C07D237/22A61K31/50
    • C07D237/22
    • A 3(2H)pyridazinone of the formula:
      wherein R₁ is hydrogen, 2-propenyl or straight chained or branched C₁-C₄ alkyl; R₂ is hydrogen or C₁-C₃ alkyl; X is chlorine or bromine; Y is hydrogen, nitro, -NHR₃ wherein R₃ is hydrogen or straight chained or branched C₁-C₄ alkyl, -AR₄ wherein A is oxygen or sulfur and R₄ is hydrogen, straight chained or branched C₁-C₆ alkyl, C₃-C₆ alkenyl having one double bond, C₃-C₆ alkynyl having one triple bond, phenyl or
      wherein R₅ is hydrogen or C₁-C₄ alkyl, or halogen; Z₁ is hydrogen, C₁-C₄ alkyl, -OR₆ wherein R₆ is hydrogen, straight chained or branched C₁-C₈ alkyl or
      wherein n is an integer of from 1 to 4, -N(R₇)₂ wherein R₇ is C₁-C₄ alkyl, or halogen; Z₂ is C₁-C₄ alkyl, -OR₆ wherein R₆ is as defined above, -N(R₇)₂ wherein R₇ is as defined above, or halogen, provided that when R₁ is straight chained or branched C₂-C₄ alkyl, Y is not hydrogen and when R₁ is hydrogen, methyl or 2-propenyl, Y and R₂ are not simultaneously hydrogen, or a pharmaceutically acceptable salt thereof.
    • 式A 3(2H)哒嗪酮: worin R1为氢,2-丙烯基或直链或支链的C1-C4烷基; R2是氢或C1-C3烷基; X是氯或溴; Y为氢,硝,-NHR 3 worin R 3是氢或直链或支链C1-C4烷基,-AR4 worin A是氧或硫,R 4是氢,直链或支链C1-C6烷基,具有一个C3-C6链烯基 双键,C 3 -C 6具有一个三键,苯基或炔worin R5是氢或C1-C4烷基,或卤素; Z1为氢,C1-C4烷基,-OR 6 worin R6是氢,直链或支链的C1-C8烷基或其中n是从1至4的整数,-N(R 7)2 worin R7是C1- C4烷基,或卤素; Z2是C1-C4烷基,-OR 6 worin R6如上述所定义,-N(R 7)2 worin R7如以上所定义,或卤素,条件做当R 1为直链或支链C2-C4烷基,Y不是氢 并且当R 1为氢,甲基或2-丙烯基,Y和R 2不都为氢。同时,或其药学上可接受的盐。